Medpace (MEDP) CFO boosts equity stake with option exercise and new RSU, option grants

Rhea-AI Filing Summary

Medpace Holdings, Inc. reported that CFO & Treasurer Kevin M. Brady exercised employee stock options for 7,000 shares of common stock at an exercise price of $138.87 per share, increasing his directly held common shares to 12,830.

On the same date, he received a grant of 5,000 restricted stock units, each representing a contingent right to one share of MEDP common stock, and a separate grant of 10,000 employee stock options with a $410.54 exercise price. The filing notes that the fully vested option exercised on April 24, 2026 had vested on February 15, 2026, while the new RSUs and options vest in full on the fifth anniversary of the grant date, subject to continued employment.

Insights

Equity compensation analyst

Brady’s Form 4 shows routine equity compensation: one option exercise and two new awards.

CFO Kevin Brady exercised 7,000 options at $138.87, converting previously granted options into common stock and raising his directly held common shares to 12,830. This is a typical exercise-and-hold pattern, with no same-day sale reported.

He also received new grants of 5,000 restricted stock units and 10,000 stock options at a $410.54 strike price, all subject to multi-year vesting based on continued employment. These awards align his incentives with future share performance but are standard executive compensation rather than a directional trading signal.

Insider Trade Summary

7,000 shares exercised/converted

Mixed 4 txns

Insider Brady Kevin M.

Role CFO & Treasurer

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy)	7,000	$0.00	--
Grant/Award	Employee Stock Option (Right to Buy)	10,000	$0.00	--
Grant/Award	Restricted Stock Unit	5,000	$0.00	--
Exercise	Common Stock	7,000	$138.87	$972K

Holdings After Transaction: Employee Stock Option (Right to Buy) — 6,803 shares (Direct, null); Restricted Stock Unit — 5,000 shares (Direct, null); Common Stock — 12,830 shares (Direct, null)

Footnotes (1)

1. The option vested in full on February 15, 2026. The option vests on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. The restricted stock units vest in full on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

Key Figures

Options exercised: 7,000 shares Exercise price: $138.87 per share Shares held after exercise: 12,830 shares +4 more

7 metrics

Options exercised 7,000 shares Employee stock options exercised for common stock on April 24, 2026

Exercise price $138.87 per share Strike price of exercised employee stock options

Shares held after exercise 12,830 shares Directly held Medpace common stock following reported transactions

RSU grant size 5,000 units Restricted stock units granted, each for one Medpace common share

New option grant 10,000 options Employee stock options granted with $410.54 exercise price

New option strike price $410.54 per share Exercise price of newly granted employee stock options

Vesting date of exercised option February 15, 2026 Footnote states option vested in full on this date

Key Terms

Restricted Stock Unit, Employee Stock Option (Right to Buy), contingent right, vests in full, +1 more

5 terms

Restricted Stock Unit financial

"The filing reports 5,000 Restricted Stock Units, each a contingent right to one share."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Employee Stock Option (Right to Buy) financial

"Two Employee Stock Option (Right to Buy) entries show grants and an exercise."

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of MEDP common stock."

vests in full financial

"The restricted stock units vest in full on the fifth anniversary of the grant date."

exercise or conversion of derivative security financial

"Transaction code M is described as Exercise or conversion of derivative security."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brady Kevin M.

(Last) (First) (Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)

CINCINNATI OHIO 45227

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO & Treasurer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/24/2026		M		7,000	A	$138.87	12,830	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$138.87	04/24/2026		M			7,000	(1)	08/15/2027	Common Stock	7,000	$0	6,803	D
Employee Stock Option (Right to Buy)	$410.54	04/24/2026		A		10,000		(2)	04/24/2033	Common Stock	10,000	$0	10,000	D
Restricted Stock Unit	(3)	04/24/2026		A		5,000		(4)	(4)	Common Stock	5,000	$0	5,000	D

Explanation of Responses:

1. The option vested in full on February 15, 2026.

2. The option vests on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

3. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

4. The restricted stock units vest in full on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.

Remarks:

	/s/ Stephen P. Ewald, Attorney-in-Fact for Kevin M. Brady	04/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Medpace (MEDP) CFO Kevin Brady report in this Form 4?

Kevin Brady reported exercising 7,000 stock options at $138.87 per share and receiving new grants of 5,000 restricted stock units and 10,000 stock options. These transactions increase his equity-based stake in Medpace through both owned shares and unvested awards.

How many Medpace (MEDP) common shares does the CFO hold after these transactions?

After exercising options, Kevin Brady directly holds 12,830 Medpace common shares. In addition, he has 5,000 restricted stock units and 10,000 stock options outstanding, which represent future rights to acquire more shares if vesting and exercise conditions are met.

What stock option exercise did the Medpace (MEDP) CFO complete?

Kevin Brady exercised 7,000 employee stock options with an exercise price of $138.87 per share, receiving 7,000 Medpace common shares. The filing notes this option had vested in full on February 15, 2026 before the reported exercise took place on April 24, 2026.

What new equity awards did Medpace (MEDP) grant to its CFO?

Medpace granted Kevin Brady 5,000 restricted stock units and 10,000 employee stock options with a $410.54 exercise price. The RSUs and options each vest in full on the fifth anniversary of the grant date, contingent on his continued employment with Medpace or its subsidiaries.

How do the restricted stock units reported for Medpace (MEDP) work?

Each of the 5,000 restricted stock units represents a contingent right to receive one share of Medpace common stock. They vest in full on the fifth anniversary of the grant date, provided Kevin Brady remains employed by Medpace or one of its subsidiaries through that vesting date.

When do the Medpace (MEDP) CFO’s new option and RSU awards vest?

Both the 5,000 restricted stock units and the 10,000 new stock options vest in full on the fifth anniversary of the grant date. Vesting is conditioned on Kevin Brady’s continued employment with Medpace or one of its subsidiaries until that fifth-anniversary vesting date.